Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 15 studies | 35% ± 19% | |
| endothelial cell of artery | 6 studies | 30% ± 17% | |
| mast cell | 6 studies | 39% ± 23% | |
| vein endothelial cell | 5 studies | 31% ± 21% | |
| glutamatergic neuron | 4 studies | 23% ± 8% | |
| megakaryocyte-erythroid progenitor cell | 3 studies | 43% ± 16% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 20% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 90% | 218.83 | 415 / 459 | 85% | 19.30 | 948 / 1118 |
| prostate | 91% | 53.49 | 224 / 245 | 76% | 3.95 | 383 / 502 |
| brain | 96% | 77.10 | 2529 / 2642 | 63% | 1.31 | 441 / 705 |
| lung | 99% | 203.45 | 575 / 578 | 36% | 1.05 | 421 / 1155 |
| skin | 67% | 33.35 | 1219 / 1809 | 68% | 7.58 | 322 / 472 |
| thymus | 90% | 45.00 | 589 / 653 | 22% | 0.37 | 134 / 605 |
| esophagus | 86% | 35.25 | 1240 / 1445 | 25% | 0.72 | 46 / 183 |
| intestine | 81% | 29.84 | 786 / 966 | 22% | 0.52 | 114 / 527 |
| kidney | 69% | 25.64 | 61 / 89 | 33% | 4.68 | 299 / 901 |
| heart | 100% | 139.56 | 859 / 861 | 0% | 0 | 0 / 0 |
| adipose | 82% | 42.05 | 983 / 1204 | 0% | 0 | 0 / 0 |
| bladder | 67% | 17.19 | 14 / 21 | 12% | 0.37 | 59 / 504 |
| ovary | 58% | 16.37 | 104 / 180 | 18% | 0.50 | 79 / 430 |
| blood vessel | 75% | 36.90 | 1006 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 66% | 17.18 | 158 / 241 | 0% | 0 | 0 / 0 |
| stomach | 44% | 12.55 | 158 / 359 | 21% | 0.44 | 59 / 286 |
| adrenal gland | 50% | 13.00 | 129 / 258 | 14% | 1.44 | 33 / 230 |
| uterus | 46% | 12.92 | 79 / 170 | 15% | 0.52 | 67 / 459 |
| muscle | 55% | 14.21 | 443 / 803 | 0% | 0 | 0 / 0 |
| liver | 52% | 12.41 | 117 / 226 | 3% | 0.05 | 13 / 406 |
| peripheral blood | 53% | 24.25 | 489 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 44% | 1.69 | 35 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 20% | 0.53 | 9 / 45 |
| pancreas | 2% | 0.35 | 8 / 328 | 10% | 0.28 | 17 / 178 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006491 | Biological process | N-glycan processing |
| GO_0001574 | Biological process | ganglioside biosynthetic process |
| GO_0001835 | Biological process | blastocyst hatching |
| GO_0009100 | Biological process | glycoprotein metabolic process |
| GO_0006493 | Biological process | protein O-linked glycosylation |
| GO_0009247 | Biological process | glycolipid biosynthetic process |
| GO_0009311 | Biological process | oligosaccharide metabolic process |
| GO_0016051 | Biological process | carbohydrate biosynthetic process |
| GO_0006486 | Biological process | protein glycosylation |
| GO_0000139 | Cellular component | Golgi membrane |
| GO_0003828 | Molecular function | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity |
| GO_0008373 | Molecular function | sialyltransferase activity |
| Gene name | ST8SIA6 |
| Protein name | Alpha-2,8-sialyltransferase 8F (EC 2.4.99.-) (Sialyltransferase 8F) (SIAT8-F) (Sialyltransferase St8Sia VI) (ST8SiaVI) ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 6 |
| Synonyms | SIAT8F |
| Description | FUNCTION: Alpha-2,8-sialyltransferase that prefers O-glycans to N-glycans or glycolipids as acceptor substrates. The minimal acceptor substrate is the NeuAc-alpha-2,3(6)-Gal sequence at the non-reducing end of their carbohydrate groups. . |
| Accessions | ENST00000377602.5 ENST00000440449.5 H0Y405 ENST00000648997.1 P61647 A0A3B3ITM3 |
